SECURITIES
AND EXCHANGE COMMISSION


Washington,
D.C.  20549





FORM
10-Q





ý
    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF


THE
SECURITIES EXCHANGE ACT OF 1934





For
Quarterly Period Ended March 31, 2009





or





o
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF


THE
SECURITIES EXCHANGE ACT OF 1934





For
the transition period from
         
to





Commission
File Number 0-21555





AMASYS
CORPORATION


(Exact
name of registrant issuer as specified in its charter)





Delaware
            
            54-1812385(State
      or other jurisdiction of incorporation or
              organization)
            
            (I.R.S.
      Employer Identification No.)625
      N. Washington Street, Suite 301,
              Alexandria,
      Virginia 22314(Address
      of principal executive offices, including zip code)Registrant’s
      phone number, including area code    (703)
      797-8111





Indicate
by check mark whether the registrant (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.


YES ý     NO
o





Indicate
by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b-2 of the Exchange Act. (Check one):


Large
Accelerated Filer o
Accelerated Filer o
Non-accelerated Filer o Smaller reporting
company ý




Indicate
by check mark whether the registrant is a shell company (as defined in Rule
12b-2 of the Exchange Act). Yes ý No o




Indicate
the number of shares outstanding of each of the issuer’s classes of common
stock, as of the latest practicable date.





Class
            
            Outstanding
      at May 11, 2009Common
      Stock, $.01 par value
            
            6,669,210























AMASYS
CORPORATION





INDEX





Page No.PART
      I
            FINANCIAL
      INFORMATIONITEM
      1.
            FINANCIAL
      STATEMENTS:Balance
      Sheets — March 31, 2009 (Unaudited) and June 30, 2008
            3Statements
      of  Operations (Unaudited) — Three and nine months ended March
      31, 2009 and 2008 and the period from entering development stage (October
      1, 2006) through March 31, 2009
            4Statements
      of Cash Flows (Unaudited) — Nine months ended March 31, 2009 and 2008 and
      the period from entering development stage (October 1, 2006) through March
      31, 2009
            5Supplemental
      Disclosure of Cash Flow Information – Nine months ended March 31, 2009 and
      2008 and the period from entering development stage (October 1, 2006)
      through March 31, 2009
            6Notes
      to Financial Statements
            7-9ITEM
      2.
            MANAGEMENT'S
      DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
      OPERATIONS
            10-14ITEM
      3.
            QUANTITATIVE
      AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
            15ITEM
      4.
            CONTROLS
      AND PROCEDURES
            15PART
      II
            OTHER
      INFORMATION
            15





-
2 -





PART I -
FINANCIAL INFORMATION





ITEM
I — FINANCIAL STATEMENTS





AMASYS
CORPORATION


(A
Development Stage Company)


BALANCE
SHEETS







March
      31,
            
            
            June
      30,2009
            
            
            2008ASSETS
            
            (Unaudited)CURRENT
      ASSETSCash
            
            $
            4,933
            
            
            $
            698Prepaid
      expenses and other current assets
            
            
            —
            
            
            
            —TOTAL
      CURRENT ASSETS
            
            
            4,933
            
            
            
            698TOTAL
      ASSETS
            
            $
            4,933
            
            
            $
            698




LIABILITIES
      AND STOCKHOLDERS’ DEFICITCURRENT
      LIABILITIES:Accounts
      payable and accrued expenses
            
            $
            16,000
            
            
            $
            1,000Accounts
      payable, related parties
            
            
            23,500
            
            
            
            15,500Notes
      payable and accrued interest, related parties
            
            
            141,769
            
            
            
            58,627TOTAL
      CURRENT LIABILITIES
            
            
            181,269
            
            
            
            75,127TOTAL
      LIABILITIES
            
            
            181,269
            
            
            
            75,127STOCKHOLDERS’
      DEFICIT:Preferred
      stock, $.01 par value, 1,000,000 shares authorized, no shares issued and
      outstanding at March 31, 2009 and June 30, 2008,
    respectively
            
            
            —
            
            
            
            —Common
      stock, $.01 par value, 20,000,000 shares authorized, 6,669,210 shares
      issued and outstanding at March 31, 2009 and June 30, 2008,
      respectively
            
            
            66,692
            
            
            
            66,692Additional
      paid in capital
            
            
            317,045
            
            
            
            317,045Accumulated
      deficit (including $196,311 accumulated during development
      stage)
            
            
            (560,073)
            
            
            
            (458,166)TOTAL
      STOCKHOLDERS’ DEFICIT
            
            
            (176,336)
            
            
            
            (74,429)TOTAL
      LIABILITIES AND STOCKHOLDERS’ DEFICIT
            
            $
            4,933
            
            
            $
            698







See
accompanying notes to the financial statements.







-
3 -


AMASYS
CORPORATION


(A
Development Stage Company)


STATEMENTS
OF OPERATIONS


(UNAUDITED)








Three
      Months Ended
              
              Nine
      Months Ended
              
              Period
      from entering Development Stage (October 1, 2006) throughMarch
      31,
              
              March
      31,
              
              March
      31,2009
              
              2008
              
              2009
              
              2008
              
              2009REVENUES
              
              $
              
              $
              
              $
              
              $
              
              $COST
      OF SALES
              
              —
              
              —
              
              —
              
              —
              
              —GROSS
      PROFIT
              
              —
              
              —
              
              —
              
              —
              
              —OPERATING
      EXPENSESGeneral
      and administrative expenses
              
              7,301
              
              9,570
              
              93,764
              
              42,787
              
              177,134Total
      operating expenses
              
              7,301
              
              9,570
              
              93,764
              
              42,787
              
              177,134LOSS
      FROM OPERATIONS
              
              (7,301)
              
              (9,570)
              
              (93,764)
              
              (42,787)
              
              (177,134)OTHER
      INCOME (EXPENSE)Interest
      expense
              
              (3,495)
              
              —
              
              (8,143)
              
              —
              
              (11,911)Stock
      issued for loans
              
              —
              
              —
              
              —
              
              —
              
              (20,000)Gain
      on sale of short term investment
              
              —
              
              —
              
              —
              
              —
              
              12,734Total
      other expense
              
              (3,495)
              
              —
              
              (8,143)
              
              —
              
              (19,177)NET
      LOSS APPLICABLE TO COMMON STOCKHOLDERS
              $              
      (10,796.00)
              
              $        
       9,570.00)
              
              $     
      101,907.00)
              
              $  
          (42,787.00)
              
              $      
       (196,311.00)NET
      LOSS PER SHARE OF COMMON STOCK --
              $                          
      0.00
              
              $               
      0.00
              
              $      
               (0.02)
              
              $                 
      0.00Basic
      and dilutedWEIGHTED
      AVERAGE SHARES OUTSTANDING --Basic and diluted
              6,669,210
              
              6,669,210
              
              6,669,210
              
              6,669,210




See
accompanying notes to the financial statements.







-
4 -





AMASYS
CORPORATION


(A
Development Stage Company)


STATEMENTS
OF CASH FLOWS


(UNAUDITED)




Nine
      Months Ended
                March
      31,
              
              
              Period
      from entering Development Stage (October 1, 2006) through
                March
      31,2009
              
              
              2008
              
              
              2009CASH
      FLOWS FROM OPERATING ACTIVITIES:Net
      loss
              
              $
              (101,907
              )
              
              $
              (42,787
              )
              
              $
              (196,311
              )Adjustments
      to reconcile net loss to net cash used in operating
      activities:Stock
      issued for loans
              
              
              -
              
              
              
              -
              
              
              
              20,000Gain
      on sale of short term investment
              
              
              -
              
              
              
              -
              
              
              
              (12,734
              )Changes
      in operating assets and liabilitiesPrepaid
      expenses and other current assets
              
              
              -
              
              
              
              700
              
              
              
              -Accounts
      payable and accrued expenses
              
              
              23,142
              
              
              
              8,902
              
              
              
              687Accounts
      payable, related parties
              
              
              8,000
              
              
              
              5,477
              
              
              
              15,972Net
      cash used in operating activities
              
              
              (70,765
              )
              
              
              (27,708
              )
              
              
              (172,386
              )CASH
      FLOWS FROM INVESTING ACTIVITIES:Net
      proceeds from sale of short term investment
              
              
              -
              
              
              
              -
              
              
              
              40,570Net
      cash provided by investing activities
              
              
              -
              
              
              
              -
              
              
              
              40,570CASH
      FLOWS FROM FINANCING ACTIVITIES:Proceeds
      from sale of common stock
              
              
              -
              
              
              
              -
              
              
              
              3,500Proceeds
      from notes payable, related parties
              
              
              75,000
              
              
              
              20,000
              
              
              
              130,000Net
      cash provided by financing activities
              
              
              75,000
              
              
              
              20,000
              
              
              
              133,500NET
      INCREASE (DECREASE) IN CASH
              
              
              4,235
              
              
              
              (7,708
              )
              
              
              1,684CASH,
      Beginning of period
              
              
              698
              
              
              
              7,862
              
              
              
              3,249CASH,
      End of period
              
              $
              4,933
              
              
              $
              154
              
              
              $
              4,933





See
accompanying notes to the financial statements.










-
5 -







AMASYS
CORPORATION


(A
Development Stage Company)


STATEMENTS
OF CASH FLOWS


(UNAUDITED)








Nine
      Months Ended
              March
      31,
            
            Period
      from entering Development Stage (October 1, 2006) through
              March
      31,2009
            
            2008
            
            2009SUPPLEMENTAL
      DISCLOSURE OF CASH FLOW INFORMATION:Cash
      received/(paid) during the period for:Interest
            
            $
            —
            
            
            $
            —
            
            $      
                             —Income
      taxes
            
            $
            —
            
            
            $
            —
            
            $                   
                —SUPPLEMENTAL
      DISCLOSURE OF NON CASH TRANSACTIONS


On
September 25, 2006, AMASYS redeemed its Series A Preferred Stock in
consideration of the outstanding promissory note, its investment in common stock
of Comtex News Network, Inc. and the issuance of 2,111,860 shares of AMASYS
Common stock.  The following table illustrates the non-cash effect of
the above transaction.





Note
      receivable, net of discount of $148,478
            
            $
            703,412Issuance
      of 2,111,860 shares of common stock
            
            
            21,119Derivative
      asset
            
            
            42,848Retirement
      of preferred stock
            
            
            (1,960)Retained
      earnings
            
            
            (282,979)Paid
      in capital
            
            
            (482,440)$
            —





See
accompanying notes to the financial statements.












-
6 -





AMASYS
CORPORATION


(A
Development Stage Company)


NOTES
TO FINANCIAL STATEMENTS


(UNAUDITED)





NOTE
1.    SUMMARY OF SIGNIFICANT ACCOUNTING
POLICIES





Organization
—AMASYS Corporation (the “Company”, “We” or “Our”) was incorporated in Delaware
in 1992, and in 1996 received all of the remaining assets of Infotechnology,
Inc. (“Infotech”), a Delaware company, following the completion of Infotech’s
Chapter 11 Bankruptcy reorganization, in accordance with an Assignment and
Assumption Agreement, dated October 11, 1996 and effective as of June 21,
1996





Basis of
Presentation — The accompanying financial statements have been prepared
in conformity with accounting principles generally accepted in the United States
of America.





The
unaudited financial statements have been prepared by us pursuant to the rules
and regulations of the Securities and Exchange Commission. The information
furnished herein reflects all adjustments (consisting of normal recurring
accruals and adjustments) which are, in the opinion of management, necessary to
fairly present the operating results for the respective periods. Certain
information and footnote disclosures normally present in annual financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America have been omitted pursuant to such rules and
regulations. These financial statements should be read in conjunction with the
audited financial statements and footnotes for the year ended June 30, 2008
included in our Annual Report on Form 10-K. The results of the three and
nine month periods ended March 31, 2009 are not necessarily indicative of
the results to be expected for the full year ending June 30, 2009.





Going
Concern — The accompanying financial statements have been prepared
assuming that we will continue as a going concern.  We have suffered
recurring losses from operations since our inception and have an accumulated
deficit of $560,073 at March 31, 2009.  The financial statements do
not include any adjustments relating to the recoverability and classification of
recorded asset amounts or amounts and classifications of liabilities that might
be necessary should we be unable to continue our existence.





In
addition, our recovery is dependent upon future events, the outcome of which is
undetermined.  We intend to continue to attempt to raise additional
capital, but there can be no certainty that such efforts will be
successful.





Development Stage
Activities - Since we redeemed and converted all of its outstanding
Series A Preferred Stock the end of September 2006, starting October 1, 2006 we
have not conducted any significant business operations. All of our operating
results and cash flows reported in the accompanying financial statements from
October 1, 2006 are considered to be those related to development stage
activities and represent the cumulative amounts from its development stage
activities required to be reported pursuant to Statements of Financial
Accounting Standards (SFAS) No. 7, Development Stage Enterprises.





Use of
Estimates — The preparation of financial statements in conformity
with generally accepted accounting principles in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. Actual results could differ
from those estimates.





Cash and Cash
Equivalents — We consider investments with original maturities of
90 days or less to be cash equivalents.





Income
Taxes — We record income taxes in accordance with the provisions of
Statement of Financial Accounting Standards (“SFAS”) No. 109, “Accounting
for Income Taxes.”  The standard requires, among other provisions, an
asset and liability approach to recognize deferred tax liabilities and assets
for the expected future tax consequences of temporary differences between the
financial statement carrying amounts and tax basis of assets and
liabilities.  Valuation allowances are provided if based upon the
weight of available evidence, it is more likely than not that some or all of the
deferred tax assets will not be realized.







-
7 -


Stock-Based
Compensation — On July 1, 2006, we adopted SFAS No. 123 (revised 2004),
“Share-Based Payment,” (“SFAS 123(R)”) which was issued in December 2004. SFAS
123(R) revises SFAS No. 123, “Accounting for Stock Based Compensation,” and
supersedes APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and
its related interpretations. SFAS 123(R) requires recognition of the cost of
employee services received in exchange for an award of equity instruments in the
financial statements over the period the employee is required to perform the
services in exchange for the award. SFAS 123(R) also requires measurement of the
cost of employee services received in exchange for an award. SFAS 123(R) also
amends SFAS No. 95, “Statement of Cash Flows,” to require the excess tax
benefits be reported as financing cash inflows, rather than as a reduction of
taxes paid, which is included within operating cash flows.





SFAS
123(R) provides that income tax effects of share-based payments are recognized
in the financial statements for those awards that will normally result in tax
deduction under existing law. Under current U.S. federal tax law, we would
receive a compensation expense deduction related to non-qualified stock options
only when those options are exercised and vested shares are received.
Accordingly, the financial statement recognition of compensation cost for
non-qualified stock options creates a deductible temporary difference which
results in a deferred tax asset and a corresponding deferred tax benefit in the
income statement. We do not recognize a tax benefit for compensation expense
related to incentive stock options unless the underlying shares are disposed in
a disqualifying disposition.





Net Income (Loss)
Per Share — We compute net loss per share in accordance with SFAS No.
128, “Earnings per Share,” and SEC Staff Accounting Bulletin No. 98 (“SAB 98”).
Under the provisions of SFAS No. 128 and SAB 98, basic and diluted net loss per
share is computed by dividing the net loss available to common stockholders for
the period by the weighted average number of shares of common stock outstanding
during the period.





Concentration of
Credit Risk — Financial instruments that potentially subject us to a
concentration of credit risk consist of cash.  We maintain our cash
with high credit quality financial institutions; at times, such balances with
any one financial institution may exceed FDIC insured limits.





Financial
Instruments — Our financial instruments consist of cash, accounts payable
and accrued expenses, and notes payable.  The carrying values of cash,
accounts payable and accrued expenses, and notes payable are representative
of their fair values due to their short-term maturities.





Comparative
Financial Statements – Certain amounts in the comparative financial
statements have been reclassified from financial statements previously presented
to confirm to the current period financial statements.





Recently
Issued Accounting Pronouncements





During
the nine months ended March 31, 2009, there were several new accounting
pronouncements issued by the Financial Accounting Standards Board (FSAB) the
most recent of which was Statements on Financial Accounting Standards (SFAS) No.
163,  Accounting for
Financial Guarantee Insurance Contracts — an interpretation of FASB Statement
No. 60.  Each of these pronouncements, as applicable, has been or
will be adopted by the Company.  Management does not believe the adoption
of any of these accounting pronouncements has had or will have a material impact
on the Company’s financial position or operating results.








NOTE
2 – INVESTMENT IN COMMON STOCK – RELATED PARTY





On September 25, 2006, AMASYS executed agreements
to redeem from the holders of its Preferred Stock, pro rata to their respective
ownership interests, 55,209 shares of AMASYS Series A Preferred Stock (the
“Series A”) in consideration for: (a) AMASYS’ entire interest in the outstanding
promissory note in favor of AMASYS made by Comtex News Network, Inc. (“Comtex”)
in the principal amount of $857,000; and (b) 2,153,437 shares of Comtex common
stock.  Pursuant to the agreement, the holders of the Series A
converted the balance of the Series A shares, together with any and all rights
to accrued but unpaid dividends thereon, into 2,111,860 shares of AMASYS Common
Stock.  Therefore, effective September 25, 2006, AMASYS no longer
owned the promissory note made by Comtex and AMASYS no longer held any shares of
Comtex common stock and therefore no longer had any ownership interest in
Comtex.





-
8 -


NOTE
3 – NOTE PAYABLE RELATED PARTY





During
the year ended June 30, 2007, we received $10,000 from Private Capital Group,
L.L.C., a shareholder of the Company.  This note has an interest rate
of 10% per annum, is unsecured and had an original due date of December 31,
2007.  The note was extended with the same terms and a due date of
December 31, 2009.  As of March 31, 2009, accrued interest payable
totaled $1,852 and is due at maturity.  Accrued interest is included
in the notes payable, related parties balance.  As an inducement to
make the loan, we issued 1,000,000 shares of restricted common stock with a fair
market value of $10,000 (par value) and issued a warrant for an additional
1,000,000 shares of restricted common stock with an exercise price of $.01 per
share.  The warrants are estimated to have no significant fair market
value.





During
the year ended June 30, 2007, we received $10,000 from Dr. C.W. Gilluly, our
Chairman of the Board, President and Chief Executive Officer.  This
note has an interest rate of 10% per annum, is unsecured and had an original due
date of December 31, 2007.  The note was extended with the same terms
and a due date of December 31, 2009.  As of March 31, 2009, accrued
interest payable totaled $1,852 and is due at maturity.  Accrued
interest is included in the notes payable, related parties
balance.  As an inducement to make the loan, we issued 1,000,000
shares of restricted common stock with a fair market value of $10,000 (par
value) and issued a warrant for an additional 1,000,000 shares of restricted
common stock with an exercise price of $.01 per share.  The warrants
are estimated to have no significant fair market value.





During
the year ended June 30, 2008, we received an additional $15,000 from Dr. C.W.
Gilluly, our Chairman of the Board, President and Chief Executive
Officer.  This note has an interest rate of 12% per annum, is
unsecured and has a due date of December 31, 2009.  As of March 31,
2009, accrued interest payable totaled $2,475 and is due at
maturity.  Accrued interest is included in the notes payable, related
parties balance.





During
the year ended June 30, 2008, we received an additional $5,000 from Private
Capital Group, L.L.C., a shareholder of the Company.  This note has an
interest rate of 12% per annum, is unsecured and has a due date of December 31,
2009.  As of March 31, 2009, accrued interest payable totaled $710 and
is due at maturity.  Accrued interest is included in the notes
payable, related parties balance.





During
the year ended June 30, 2008, we received an additional $15,000 from Dr. C.W.
Gilluly, our Chairman of the Board, President and Chief Executive
Officer.  This note has an interest rate of 12% per annum, is
unsecured and has a due date of December 31, 2009.  As of March 31,
2009, accrued interest payable totaled $1,390 and is due at
maturity.  Accrued interest is included in the notes payable, related
parties balance.





During
the quarter ended September 30, 2008, we received an additional $25,000 from Dr.
C.W. Gilluly, our Chairman of the Board, President and Chief Executive
Officer.  This note has an interest rate of 12% per annum, is
unsecured and has a due date of December 31, 2009.  As of March 31,
2009, accrued interest payable totaled $1,619 and is due at
maturity.  Accrued interest is included in the notes payable, related
parties balance.





During
the quarter ended December 31, 2008, we received an additional $40,000 from Dr.
C.W. Gilluly, our Chairman of the Board, President and Chief Executive
Officer.  This note has an interest rate of 12% per annum, is
unsecured and has a due date of December 31, 2009.  As of March 31,
2009, accrued interest payable totaled $1,844 and is due at
maturity.  Accrued interest is included in the notes payable, related
parties balance.





During
the quarter ended March 31, 2009, we received an additional $10,000 from Dr.
C.W. Gilluly, our Chairman of the Board, President and Chief Executive
Officer.  This note has an interest rate of 12% per annum, is
unsecured and has a due date of December 31, 2009.  As of March 31,
2009, accrued interest payable totaled $27 and is due at
maturity.  Accrued interest is included in the notes payable, related
parties balance.








NOTE
4 – STOCK WARRANTS





During
the year ended June 30, 2007, we issued two warrants as part of an incentive for
two notes payable, related parties.  The warrants are for the purchase
of 2,000,000 shares of restricted common stock at an exercise price of
$.01.  The warrants are estimated to have no significant fair market
value using the Black Scholes method of calculation and the warrants expire in
2017.





-
9 -


ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS





The
information contained in this Form 10-Q is intended to update the information
contained in our Annual Report on Form 10-K for the year ended June 30, 2008 and
presumes that readers have access to, and will have read, the “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” and
other information contained in such Form 10-K.  The following
discussion and analysis also should be read together with our financial
statements and the notes to the financial statements included elsewhere in this
Form 10-Q.





The
following discussion contains certain statements that may be deemed
“forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995.  Such statements appear in a number of
places in this Report, including, without limitation, “Management’s Discussion
and Analysis of Financial Condition and Results of Operations.”  These
statements are not guarantees of future performance and involve risks,
uncertainties and requirements that are difficult to predict or are beyond our
control.  Forward-looking statements speak only as of the date of this
quarterly report. You should not put undue reliance on any forward-looking
statements.  We strongly encourage investors to carefully read the
factors described in our Annual Report on Form 10-K for the year ended June 30,
2008 in the section entitled “Risk Factors” for a description of certain risks
that could, among other things, cause actual results to differ from these
forward-looking statements. We assume no responsibility to update the
forward-looking statements contained in this quarterly report on Form 10-Q. The
following should also be read in conjunction with the unaudited Financial
Statements and notes thereto that appear elsewhere in this report.





Company
History





AMASYS
Corporation (“AMASYS”, the “Company,” us, we or our) was incorporated in
Delaware in 1992, and in 1996 received all remaining assets of Infotechnology,
Inc. (“Infotech”), a Delaware company, following the completion of Infotech’s
Chapter 11 Bankruptcy reorganization, in accordance with an Assignment and
Assumption Agreement, dated October 11, 1996, and effective as of June 21,
1996.  As a result of a series of transactions during the 1980’s,
Infotech, then principally engaged in the information and communications
business, acquired equity interests in Comtex News Network, Inc. (“Comtex”) and
Analex Corporation (“Analex”), formerly known as Hadron,
Inc.   As of December 31, 2006 AMASYS no longer had an equity
interest in Comtex and no longer had an equity interest in Analex.




Overview




AMASYS is
the successor to Infotech, pursuant to Infotech’s bankruptcy
proceeding.  Until September 25, 2006, AMASYS’ primary assets were its
equity interest in and note receivable (the “Note”) from Comtex and an equity
interest in Analex.  AMASYS owned 16% of the outstanding equity of
Comtex, while the remainder was publicly owned.





On
September 25, 2006, we exchanged the equity investment in Comtex common stock
and the Note Receivable from Comtex of $856,954, for 55,209 shares of the AMASYS
Series A Preferred stock.  Therefore, at September 30, 2006, we no
longer had an equity interest in either the common stock of Comtex or the Note
from Comtex.





During
October 2006, we sold the remaining 21,000 shares of common stock of
publicly-held Analex, a defense contractor specializing in systems engineering
and developing innovative technical intelligence solutions in support of U.S.
national security.  Therefore, at December 31, 2008, we no longer had
an equity interest in Analex.





Since we
redeemed and converted all of the outstanding Series A Preferred Stock at the
end of September 2006, starting October 1, 2006 we have not conducted any
business operations.







-
10 -


Critical Accounting
Policies





Our
financial statements were prepared in conformity with U.S. generally accepted
accounting principles.  As such, management is required to make
certain estimates, judgments and assumptions that they believe are reasonable
based upon the information available.  These estimates and assumptions
affect the reported amounts of assets and liabilities at the date of the
financial statements and the reported amounts of income and expense during the
periods presented.  The significant accounting policies which
management believes are the most critical to aid in fully understanding and
evaluating our reported financial results include the following:





Derivatives





SFAS
133 establishes accounting and reporting standards for derivative instruments
and requires that all derivatives be recorded on the balance sheet at fair
value.  Additionally, the accounting for changes in fair value depends
on whether the derivative instrument is designated and qualifies as part of a
hedging relationship and, if so, the nature of the hedging
activity.  Changes in the fair value of derivatives that do not
qualify for hedge treatment are recognized currently in earnings.





We
had a Note from Comtex and in August 2001, the Note was amended to include a
provision that allows us to convert all or a portion of the outstanding
principal amount, plus accrued interest, into common stock of
Comtex.  In accordance with SFAS 133, we accounted for this conversion
option as an embedded derivative.  As a result, the conversion option
was being carried at fair value determined using a Black-Scholes model with
changes in the fair value being recognized currently in earnings.  As
previously reported, on September 25, 2006, we exchanged the Note for shares of
the AMASYS Series A Preferred stock. Therefore, as of December 31, 2008,
the balance of the derivative asset was $-0-.





Investment
in Comtex





As
previously reported, on September 25, 2006, we exchanged the equity investment
in Comtex common for shares of the AMASYS Series A Preferred
stock.  Therefore, at September 30, 2006, we no longer had an equity
interest in the common stock of Comtex.  At June 30, 2006, we had a
16% ownership interest in Comtex.  Since we had the ability to
significantly influence the operations of Comtex, we accounted for our
investment in Comtex under the equity method of accounting.  We could
significantly influence the operations of Comtex since (i) if we converted our
note receivable-related party into shares of Comtex, we would have had a 21%
ownership interest in Comtex, (ii) the Company as well as our Chairman and CEO
were Comtex’s largest individual shareholders, (iii) the Company and our
Chairman and CEO had a combined ownership interest in Comtex of 37%, and (iv)
our Chairman is the Chairman of the Board of Comtex.  During the year
ended June 30, 2008, we did not recognize any income or loss as we did not have
any investment in Comtex.  During the year ended June 30, 2007, we
recognized income of $9,127 for our share of Comtex income.





Valuation
of Deferred Tax Assets





We recognize deferred tax assets and liabilities based on the
difference between the financial statement and tax bases of assets and
liabilities.  We regularly review our deferred tax assets for
recoverability and establish a valuation allowance based on historical taxable
income, projected future taxable income and the expected timing of the reversals
of existing temporary differences.  Based upon the level of historical
taxable income and projections for future taxable income over the periods in
which the net operating loss carryforwards are available to reduce income taxes
payable, we have established a full valuation allowance against the deferred tax
assets.





We base
our estimates on historical experience and on various other assumptions that are
believed to be reasonable under the circumstances, the results of which form the
basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. There can be no assurance that
actual results will not differ from these estimates.


-
11 -


For the Three and Nine
Months Ended March 31, 2009 and 2008





Results
of Operations





General
and Administrative Expenses





General
and administrative expenses were $7,301 and $9,570 for the three months ended
March 31, 2009 and 2008, respectively and $93,764 and $42,787 for the nine
months ended March 31, 2009 and 2008, respectively.  The increase in
general and administrative expenses for the nine months ended March 31, 2009 was
mainly due to increased professional fees associated with audit and accounting
fees for our various SEC filings.





Other
Income (Expense)





Other
income (expense) was $(3,495) and $-0- for the three months ended March 31, 2009
and 2008, respectively, and ($8,143) and $-0- for the nine months ended March
31, 2009 and 2008, respectively.  The increase is primarily due to the
additional interest expense incurred on our additional notes payable, related
parties.





Liquidity
and Capital Resources





Net cash used in operating activities was
$70,765 and $27,708 in the nine months ended March 31, 2009 and 2008,
respectively.  The increase was primarily due to the additional losses
for the nine months ended March 31, 2009 compared to 2008.





Net cash
provided by investing activities was $-0- and $-0- in the nine months ended
March 31, 2009 and 2008, respectively.





Net cash
provided by financing activities was $75,000 and $20,000 in the nine months
ended March 31, 2009 and 2008, respectively.  The increase in cash
provided by financing activities was due to the proceeds from notes payable,
related party.





We
suffered recurring losses from operations and have an accumulated deficit of
$560,073 at March 31, 2009.  Currently, we are a non-operating public
company. We seek suitable candidates for a business combination with a private
company.  In the event we use all of our cash resources, C.W. Gilluly
has indicated the willingness to loan us funds at the prevailing market rate,
assuming we find a suitable candidate for a business combination, until such
business combination is consummated.  Even though this is Mr.
Gilluly's current intention, he has made no firm commitment and it is at his
sole discretion whether or not to fund us.  In the event Mr. Gilluly
does not fund us, we will not have the funds necessary to operate and will have
to dissolve.





Inflation and
Seasonality





Inflation
has not been material to us during the past five years. Seasonality has not been
material to us.





Off-Balance Sheet
Arrangements





We have
no off-balance sheet arrangements.





-
12 -


Risk
Factors





The
following important factors, and the important factors described elsewhere in
this report or in our other filings with the SEC, could affect (and in some
cases have affected) our results and could cause our results to be materially
different from estimates or expectations.  Other risks and
uncertainties may also affect our results or operations
adversely.  The following and these other risks could materially and
adversely affect our business, operations, results or financial
condition.





We
have a history of net losses and may never achieve or maintain
profitability.





We have a
history of incurring losses from operations. As of March 31, 2009, we had an
accumulated deficit of $560,073.   We are currently funding our
operations through loans. Our ability to continue may prove more expensive than
we currently anticipate and we may incur significant additional costs and
expenses.





We
are a non-operating company seeking a suitable transaction and may not find a
suitable candidate or transaction.





We are a
non-operating company.  If we are unable to consummate a transaction
or become profitable we will be forced to liquidate and dissolve which will take
three years to complete and may result in our distributing less cash to our
shareholders.  Additionally, we will be spending cash during the
winding down and may not have enough cash to distribute to our
shareholders.




We
will continue to incur claims, liabilities and expenses that will reduce the
amount available for distribution to stockholders.





Claims,
liabilities and expenses incurred while seeking a private company transaction or
any subsequent dissolution, such as legal, accounting and consulting fees and
miscellaneous office expenses, will reduce the amount of assets available for
future distribution to stockholders. If available cash and amounts received on
the sale of non-cash assets are not adequate to provide for our obligations,
liabilities, expenses and claims, we may not be able to distribute meaningful
cash, or any cash at all, to our stockholders.





We
will continue to incur the expenses of complying with public company reporting
requirements.




We have
an obligation to continue to comply with the applicable reporting requirements
of the Securities Exchange Act of 1934, as amended, even though compliance with
such reporting requirements is economically burdensome.





Our auditors have expressed a going
concern opinion .





Primarily
as a result of our recurring losses and our lack of liquidity, we received a
report from our independent auditors that includes an explanatory paragraph
describing the substantial uncertainty as to our ability to continue as a going
concern for the year ended June 30, 2008.




Any future
sale of a substantial number of shares of our common stock could depress the
trading price of our common stock.





Any sale
of a substantial number of shares of our common stock (or the prospect of sales)
may have the effect of depressing the trading price of our common stock. In
addition, these sales could lower our value.





-
13 -


Our
stock price is likely to be highly volatile because of several factors,
including a limited public float.





The
market price of our stock is likely to be highly volatile because there has been
a relatively thin trading market for our stock, which causes trades of small
blocks of stock to have a significant impact on our stock price. You may not be
able to resell our common stock following periods of volatility because of the
market's adverse reaction to volatility.





Other
factors that could cause such volatility may include, among other
things:





·
            announcements
      concerning our strategy;





·
            litigation;
      and





·
            general
      market conditions.





Because
our common stock is considered a "penny stock" any investment in our common
stock is considered to be a high-risk investment and is subject to restrictions
on marketability.





Our
common stock is currently listed on the Pink Sheets and is considered a "penny
stock." The Pink Sheets is generally regarded as a less efficient trading market
than the NASDAQ Capital Market.





The SEC
has adopted rules that regulate broker-dealer practices in connection with
transactions in "penny stocks." Penny stocks generally are equity securities
with a price of less than $5.00 (other than securities registered on certain
national securities exchanges or quoted on the NASDAQ system, provided that
current price and volume information with respect to transactions in such
securities is provided by the exchange or system). The penny stock rules require
a broker-dealer, prior to a transaction in a penny stock not otherwise exempt
from those rules, to deliver a standardized risk disclosure document prepared by
the SEC, which specifies information about penny stocks and the nature and
significance of risks of the penny stock market. The broker-dealer also must
provide the customer with bid and offer quotations for the penny stock, the
compensation of the broker-dealer and any salesperson in the transaction, and
monthly account statements indicating the market value of each penny stock held
in the customer's account. In addition, the penny stock rules require that,
prior to a transaction in a penny stock not otherwise exempt from those rules,
the broker-dealer must make a special written determination that the penny stock
is a suitable investment for the purchaser and receive the purchaser's written
agreement to the transaction. These disclosure requirements may have the effect
of reducing the trading activity in the secondary market for our common
stock.





Since our
common stock is subject to the regulations applicable to penny stocks, the
market liquidity for our common stock could be adversely affected because the
regulations on penny stocks could limit the ability of broker-dealers to sell
our common stock and thus your ability to sell our common stock in the secondary
market.  There is no assurance our common stock will be quoted on
NASDAQ or the NYSE or listed on any exchange, even if eligible.





-
14 -


ITEM
3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK





A smaller
reporting company is not required to provide the information required by
this Item.





ITEM
4 - CONTROLS AND PROCEDURES





EVALUATION OF DISCLOSURE CONTROLS AND
PROCEDURES.   Our management, with the participation of our
president and our chief financial officer, carried out an evaluation of the
effectiveness of our "disclosure controls and procedures" (as defined in
the Securities Exchange Act of 1934 (the "Exchange Act") Rules 13a-15(e)
and 15-d-15(e)) as of the end of the period covered by this report (the
"Evaluation Date"). Based upon that evaluation, our President and our
Chief Financial Officer concluded that, as of the Evaluation Date, our
disclosure controls and procedures are effective to ensure that information
required to be disclosed by us in the reports that we file or submit under
the Exchange Act (i) is recorded, processed, summarized and reported,
within the time periods specified in the SEC's rules and forms and (ii) is
accumulated and communicated to our management, including our President and
our Chief Financial Officer, as appropriate to allow timely decisions
regarding required disclosure.




CHANGES IN INTERNAL CONTROL OVER
FINANCIAL REPORTING.   There were no changes in our internal
controls over financial reporting that occurred during the period that have
materially affected, or are reasonably likely to materially affect, our internal
controls over financial reporting. We believe that a control system, no matter
how well designed and operated, cannot provide absolute assurance that the
objectives of the control system are met, and no evaluation of controls can
provide absolute assurance that all control issues and instances of fraud, if
any, within any company have been detected.





PART
II - OTHER INFORMATION





ITEM
      6.
            
            Exhibits31
            Certification
      of President pursuant to Exchange Act Rule 13a-14 and 15d-14 as adopted
      pursuant to section 302 of the Sarbanes-Oxley Act of
  2002.32
            Certification
      of the Company’s Chief Executive Officer, pursuant to 18 U.S.C. Section
      1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
      2002.





-
15 -


SIGNATURES





Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.





AMASYS
      CORPORATIONDate:
      May 14, 2009
            /s/ 
      C.W. GillulyName:
      C.W. Gilluly, Ed.D.Title: President
      and Chief Executive Officer





-
16 -


EXHIBIT
INDEX








Exhibit
            
            Description31
            
            Certification
      of President pursuant to Exchange Act Rule 13a-14 and 15d-14 as adopted
      pursuant to section 302 of the Sarbanes-Oxley Act of
  2002.32
            
            Certification
      of the Company’s Chief Executive Officer, pursuant to 18 U.S.C. Section
      1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
      2002.


-
17 -